ADC Therapeutics

Dear Board:

Now that Ameet and CHS have had over a year to implement their plan lets take a look shall we:
1. Ameet too over with the stock around 10, it is now under 3.
2. KHS wanted to implement her plan with the go to market approach. She cut loose many and many other good reps left. Lets look: No one joining this company has any good options. You have some stay cause they want their title promotion but no one worth a damn joins. Except the several people who have used ADCT to work several jobs at once.
3. Marketing genius Karen has implemented ? Nevermind she is useless too.
You keep creating debt to have a cash balance but no one wants to absord the debt. You are the only ADC company with a drug on the market yet no one is looking to buy.

I can't decide who has created more harm to shareholders managment or the board. You should all take a long look in the mirror and take a personal inventory of your career. You are all leeches!
Dear Board:

All of the above is still true. Ameet is now working on crafting his message to the 3 new MBA's who will be on the earnings call trying to explain how a drug that has flatlined again at 18 million per quarter is going to be a 500m-1 billion dollar drug. The pipeline is gone and the only thing he does is restructure debt to kick the can down the road, meanwhile the stock is under 2 dollars. Are you overseeing a company or a charity for ex novartis leadership? You have all failed in your oversight duties.